Cartesian Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-65.3M | $-36.2M | $-25.2M | $-12.9M |
| Depreciation & Amortization | — | — | — | — |
| Depreciation | $750.0K | $802.0K | $1.0M | $864.0K |
| Amortization | — | — | — | — |
| Stock-Based Compensation | $4.1M | — | — | — |
| Net Cash from Operating Activities | $-52.0M | $-19.8M | $-22.5M | $-12.7M |
| Investing Activities | ||||
| Capital Expenditures | $733.0K | $586.0K | $1.2M | $227.0K |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $-2.1M | $-22.1M | $-4.7M | — |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $66.0M | $67.7M | $43.9M | — |
| Net Change in Cash | $12.0M | $26.3M | $15.7M | $8.5M |
| Free Cash Flow | $-52.8M | $-20.3M | $-23.6M | $-12.9M |